Does systemic inflammation suppress steroid hormone production and cause tissue steroid resistance?

Systemic inflammation acts as a significant endocrine disruptor, creating a state where the immune system prioritized immediate stress responses over long-term reproductive and metabolic homeostasis. This interaction occurs through both the direct inhibition of hormone production and the induction of functional resistance at target tissues.

Suppression of steroidogenesis

Pro-inflammatory cytokines, specifically TNF-α, IL-6, and IL-1β, directly impair the synthesis of steroid hormones in the gonads and adrenal glands.

• Gonadal inhibition: In gonadal tissues, these cytokines activate NF-κB and MAPK pathways that downregulate the Steroidogenic Acute Regulatory (StAR) protein. Because StAR is the rate-limiting transporter of cholesterol into the mitochondria, its suppression significantly reduces the precursor availability for all sex steroids.
• Adrenal shifting: In the adrenal glands, chronic inflammation triggers a "dissociation" of glucocorticoids and androgens. While IL-6 may acutely support cortisol production, it simultaneously inhibits the 17,20-lyase activity of the CYP17A1 enzyme and downregulates SULT2A1. This results in decreased levels of DHEA and DHEA-S, often leadings to a state of relative adrenal androgen deficiency despite normal cortisol levels.

Reduced tissue responsiveness

Beyond lowering circulating hormone levels, inflammation induces systemic steroid resistance, meaning tissues respond poorly even to physiological or therapeutic hormone concentrations.

• Receptor downregulation: NF-κB signaling directly suppresses the transcription of the ESR1 (estrogen receptor alpha) and AR (androgen receptor) genes, reducing the total number of available receptors.
• Cofactor sequestration: A critical mechanism of resistance is competition for limited nuclear coactivators. Activated NF-κB subunits (p65/RelA) sequester essential coactivators such as p300/CBP and SRC-1, preventing them from facilitating the transcriptional activity of steroid receptors.
• Transcriptional remodeling: Inflammatory signals can cause post-translational modifications (e.g., phosphorylation) of steroid receptors, leading to their premature degradation or forcing them to bind to non-classical genomic sites, effectively "reprogramming" the cellular response to hormones.

Bottom line

Systemic inflammation suppresses steroid hormone synthesis by downregulating the StAR protein and key enzymes like CYP17A1, while simultaneously inducing tissue resistance through receptor downregulation and cofactor competition. This creates a dual deficit of both hormone availability and hormone efficacy.